Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
721.09B | 720.58B | 713.77B | 768.11B | 733.58B | Gross Profit |
209.59B | 210.88B | 209.68B | 225.64B | 210.60B | EBIT |
16.93B | 19.19B | 18.80B | 26.79B | 12.28B | EBITDA |
25.44B | 30.17B | 30.52B | 38.27B | 23.80B | Net Income Common Stockholders |
9.02B | 11.39B | 13.11B | 16.63B | 10.98B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
12.01B | 13.23B | 29.89B | 43.07B | 15.97B | Total Assets |
431.69B | 369.37B | 377.97B | 386.21B | 350.02B | Total Debt |
91.21B | 46.02B | 55.56B | 56.77B | 59.37B | Net Debt |
79.20B | 32.78B | 25.67B | 13.69B | 43.39B | Total Liabilities |
216.77B | 167.71B | 178.49B | 192.37B | 169.62B | Stockholders Equity |
214.61B | 201.66B | 199.48B | 193.84B | 180.40B |
Cash Flow | Free Cash Flow | |||
-49.61B | 9.89B | 8.63B | 40.87B | 23.87B | Operating Cash Flow |
19.96B | 12.14B | 10.58B | 42.96B | 25.28B | Investing Cash Flow |
-68.72B | -8.34B | -10.52B | -7.97B | -5.56B | Financing Cash Flow |
47.53B | -20.45B | -13.24B | -7.89B | -12.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥119.06B | 14.29 | 5.13% | 4.38% | 10.39% | ||
74 Outperform | ¥282.79B | 24.78 | 16.52% | 3.61% | 2.93% | 8.93% | |
73 Outperform | $3.74T | 130.14 | 2.60% | 0.86% | 6.08% | -35.70% | |
68 Neutral | ¥200.05B | 15.27 | 2.34% | 5.06% | 23.42% | ||
68 Neutral | ¥333.93B | 8.68 | 8.38% | 2.09% | 6.94% | 26.04% | |
61 Neutral | $6.66B | 11.77 | 3.06% | 3.96% | 2.60% | -21.54% | |
61 Neutral | ¥48.39B | 20.30 | 1.31% | 16.65% | -9.43% |